{"id":"acei-treatment","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Persistent dry cough"},{"rate":"1-5","effect":"Hyperkalemia"},{"rate":"5-10","effect":"Dizziness"},{"rate":"0.1-0.5","effect":"Angioedema"},{"rate":"5-10","effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ACE inhibitors prevent the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This leads to vasodilation, reduced aldosterone secretion, and decreased sodium and water retention, resulting in lower blood pressure and reduced cardiac workload. They are commonly used in hypertension and heart failure management.","oneSentence":"ACE inhibitors block the angiotensin-converting enzyme, reducing the production of angiotensin II and lowering blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:41:28.720Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Heart failure"},{"name":"Post-myocardial infarction"},{"name":"Diabetic nephropathy"}]},"trialDetails":[{"nctId":"NCT07493603","phase":"PHASE1, PHASE2","title":"A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease","status":"RECRUITING","sponsor":"Xia Liang","startDate":"2026-01-16","conditions":"Coronary Heart Disease, Coronary Artery Disease, Atheroscleroses","enrollment":30},{"nctId":"NCT04367883","phase":"","title":"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection","status":"RECRUITING","sponsor":"Consorci Sanitari de Terrassa","startDate":"2020-03-01","conditions":"COVID19, Influenza Vaccination, ACE Inhibitors","enrollment":3000},{"nctId":"NCT06797518","phase":"PHASE2","title":"Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-21","conditions":"Glomerulonephritis, IGA, Immunoglobulin A Nephropathy","enrollment":20},{"nctId":"NCT05457283","phase":"PHASE3","title":"A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria","status":"RECRUITING","sponsor":"Bayer","startDate":"2022-11-08","conditions":"Chronic Kidney Disease, Proteinuria, Children","enrollment":100},{"nctId":"NCT07478328","phase":"PHASE2","title":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Longhua Hospital","startDate":"2026-03-08","conditions":"Ischemic Heart Disease","enrollment":60},{"nctId":"NCT04789733","phase":"NA","title":"The GUARDIAN Pilot Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-04-27","conditions":"General Surgery","enrollment":80},{"nctId":"NCT07465666","phase":"","title":"A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-04-01","conditions":"Hypertension","enrollment":500},{"nctId":"NCT02627196","phase":"NA","title":"Baroreflex Activation Therapy for Heart Failure","status":"COMPLETED","sponsor":"CVRx, Inc.","startDate":"2016-04-19","conditions":"Heart Failure","enrollment":1090},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT04456816","phase":"PHASE2","title":"A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria","status":"RECRUITING","sponsor":"SynAct Pharma Aps","startDate":"2020-08-31","conditions":"Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy","enrollment":23},{"nctId":"NCT06578078","phase":"PHASE3","title":"A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients","status":"RECRUITING","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2024-10-03","conditions":"Heart Failure, Chronic Kidney Diseases","enrollment":94},{"nctId":"NCT07167368","phase":"NA","title":"Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients","status":"RECRUITING","sponsor":"Haiyan Pan","startDate":"2025-09-15","conditions":"Cardiorenal Syndrome","enrollment":60},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":"Acute Myocarditis","enrollment":300},{"nctId":"NCT06128980","phase":"PHASE2, PHASE3","title":"Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy","status":"RECRUITING","sponsor":"Herlev and Gentofte Hospital","startDate":"2025-01-09","conditions":"Heart Failure With Reduced Ejection Fraction, Heart Rhythm Disorder","enrollment":348},{"nctId":"NCT07292493","phase":"","title":"Immune System in Diabetic Kidney Disease","status":"ENROLLING_BY_INVITATION","sponsor":"University Medical Centre Ljubljana","startDate":"2025-12-01","conditions":"Diabetes, Diabetic Kidney Disease, Complement System","enrollment":90},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT03051282","phase":"PHASE4","title":"Genetic Determinants of ACEI Prodrug Activation","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2017-04-01","conditions":"Healthy Volunteers","enrollment":21},{"nctId":"NCT07044700","phase":"","title":"Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2028-01-31","conditions":"Heart Failure of Reduced Ejection Fraction (HFrEF)","enrollment":5000},{"nctId":"NCT06526195","phase":"NA","title":"Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure","status":"RECRUITING","sponsor":"Abbott Medical Devices","startDate":"2024-12-13","conditions":"Heart Failure, Heart Diseases, Cardiovascular Diseases","enrollment":850},{"nctId":"NCT07099677","phase":"NA","title":"Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk","status":"RECRUITING","sponsor":"Abant Izzet Baysal University","startDate":"2025-08-01","conditions":"Hypertension, Fall Risk, Postural Balance","enrollment":186},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT07391267","phase":"NA","title":"Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-02-01","conditions":"Chronic Kidney Diseases, MAFLD","enrollment":90},{"nctId":"NCT05196035","phase":"PHASE3","title":"A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria","status":"RECRUITING","sponsor":"Bayer","startDate":"2022-03-28","conditions":"Chronic Kidney Disease, Proteinuria","enrollment":219},{"nctId":"NCT05780710","phase":"NA","title":"OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake","status":"RECRUITING","sponsor":"Aktiia SA","startDate":"2023-06-29","conditions":"Hypertension","enrollment":35},{"nctId":"NCT07376265","phase":"","title":"A Real-world Study to Compare the Effectiveness of Sacubitril/Valsartan Versus ACEi/ARB in HFrEF Patients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2023-10-20","conditions":"Heart Failure","enrollment":1249},{"nctId":"NCT06299514","phase":"NA","title":"RAFT - Pace &Ablate","status":"RECRUITING","sponsor":"Habib Khan","startDate":"2024-04-25","conditions":"Atrial Fibrillation, Heart Failure, Pacemaker","enrollment":600},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT07303556","phase":"NA","title":"Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nazarbayev University","startDate":"2024-12-18","conditions":"Heart Failure, Diabete Type 2, Arterial Hypertension","enrollment":120},{"nctId":"NCT04591210","phase":"PHASE3","title":"The COVID-RASi Trial (COVID-19)","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2021-01-27","conditions":"COVID-19, Cardiovascular Diseases","enrollment":372},{"nctId":"NCT04849806","phase":"","title":"Sympathetic Nerve Activity Predictors in Patients With Chronic Obstructive Pulmonary Disease","status":"RECRUITING","sponsor":"RWTH Aachen University","startDate":"2022-05-10","conditions":"COPD, Sympathetic Nervous System Diseases, Catecholamine; Overproduction","enrollment":135},{"nctId":"NCT07355023","phase":"NA","title":"AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Target Trial Emulation Study","status":"RECRUITING","sponsor":"Tri-Service General Hospital","startDate":"2026-01-01","conditions":"Left Ventricular (LV) Systolic Dysfunction","enrollment":5000},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT07356388","phase":"PHASE3","title":"FINEPKT - Finerenone in Proteinuria Patients After Kidney Transplan","status":"ACTIVE_NOT_RECRUITING","sponsor":"kewen Chen,MD","startDate":"2025-01-30","conditions":"Kidney Transplantation Recipients, Proteinuria Patients","enrollment":54},{"nctId":"NCT07348718","phase":"","title":"Rubix LS Diabetic Kidney Disease (DKD) Registry Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rubix LS","startDate":"2025-12-15","conditions":"Diabetic Kidney Disease (DKD)","enrollment":2000},{"nctId":"NCT07334197","phase":"NA","title":"Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-12-20","conditions":"Ppm, Cardiomyopathy","enrollment":25},{"nctId":"NCT07315191","phase":"PHASE4","title":"Finerenone Therapy for Pediatric HSPN With Mild Proteinuria","status":"RECRUITING","sponsor":"Capital Institute of Pediatrics, China","startDate":"2025-06-13","conditions":"Henoch Schönlein Purpura Nephritis","enrollment":116},{"nctId":"NCT05834803","phase":"NA","title":"Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2023-06-26","conditions":"Renovascular Hypertension, Renovascular Hypertension With Renal Failure, Heart Failure","enrollment":80},{"nctId":"NCT07315139","phase":"NA","title":"Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-02-01","conditions":"Pentoxifylline, Inflammatory Markers, Non-Diabetic","enrollment":42},{"nctId":"NCT06023576","phase":"PHASE2","title":"A Study of Blood Pressure Control During Cancer Treatment","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-18","conditions":"Breast Cancer, Cardiotoxicity","enrollment":130},{"nctId":"NCT07309094","phase":"","title":"Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD","status":"RECRUITING","sponsor":"Cardenal Herrera University","startDate":"2023-09-15","conditions":"Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 1","enrollment":250},{"nctId":"NCT07311109","phase":"NA","title":"A Prospective, Single-center, Randomized Controlled Clinical Study Evaluating the Efficacy and Safety of Hyperbaric Oxygen Therapy as an Adjunctive Treatment for Chronic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Fujian Medical University","startDate":"2025-12-15","conditions":"Chronic Heart Failure With Reduced Ejection Fraction","enrollment":150},{"nctId":"NCT05764057","phase":"PHASE3","title":"DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06-12","conditions":"AMI, STEMI, NSTEMI","enrollment":450},{"nctId":"NCT07295522","phase":"PHASE4","title":"Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?","status":"NOT_YET_RECRUITING","sponsor":"IRCCS Policlinico S. Donato","startDate":"2026-01-08","conditions":"Heart Failure, Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)","enrollment":368},{"nctId":"NCT02770066","phase":"","title":"A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2015-01-01","conditions":"Renal Artery Obstruction, Hypertension, Renovascular, Cardiovascular Diseases","enrollment":160},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT05106036","phase":"NA","title":"Preventing Cognitive Decline by Reducing BP Target Trial","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-07-11","conditions":"Cognitive Decline, Blood Pressure, Hypertension","enrollment":4000},{"nctId":"NCT06183437","phase":"PHASE4","title":"The STOP-MED CTRCD Trial","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-03-04","conditions":"Heart Failure, Cardiotoxicity, Cardiac Toxicity","enrollment":335},{"nctId":"NCT07110415","phase":"PHASE4","title":"Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction","status":"RECRUITING","sponsor":"SPH Qingdao Growful Pharmacetical Co.,Ltd","startDate":"2025-11-06","conditions":"Coronary Heart Disease, Cardiac Dysfunction","enrollment":2708},{"nctId":"NCT04980716","phase":"PHASE3","title":"Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-06-01","conditions":"Non-small Cell Lung Cancer, Cardiovascular Complication","enrollment":524},{"nctId":"NCT06697353","phase":"","title":"An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan","status":"COMPLETED","sponsor":"Bayer","startDate":"2024-11-01","conditions":"Chronic Heart Failure, Chronic Heart Failure With Reduced Ejection Fraction","enrollment":4936},{"nctId":"NCT03418961","phase":"PHASE3","title":"S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2017-11-01","conditions":"Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain","enrollment":491},{"nctId":"NCT04983823","phase":"NA","title":"Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)","status":"RECRUITING","sponsor":"Baker Heart and Diabetes Institute","startDate":"2021-11-18","conditions":"Heart Failure","enrollment":820},{"nctId":"NCT07197372","phase":"","title":"Comparative Efficacy of ARNI Versus ACE Inhibitor Therapy in Egyptian Children With Dilated Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05-30","conditions":"ARNI, Pediatric Dilated Cardiomyopathy, ACE Inhibitor","enrollment":70},{"nctId":"NCT06700213","phase":"","title":"Guideline Directed Medical Therapy in Patients With Heart Failure","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2023-09-22","conditions":"Heart Failure","enrollment":300},{"nctId":"NCT05180773","phase":"PHASE4","title":"Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy","status":"RECRUITING","sponsor":"Dennis M. McNamara, MD, MS","startDate":"2022-07-27","conditions":"Peripartum Cardiomyopathy, Postpartum","enrollment":250},{"nctId":"NCT07184918","phase":"NA","title":"Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-02-01","conditions":"Contrast-Induced Nephropathy, Coronary Angiography, Acute Kidney Injury","enrollment":44},{"nctId":"NCT04486118","phase":"PHASE2","title":"Centrally Acting ACE Inhibition in SLE","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwell Health","startDate":"2021-10-01","conditions":"Systemic Lupus Erythematosus","enrollment":36},{"nctId":"NCT07175948","phase":"","title":"Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-06-01","conditions":"Myocarditis, Myocarditis Acute","enrollment":100},{"nctId":"NCT04753840","phase":"NA","title":"Long-term of Remote Ischemic Preconditioning in Patients With Mild Hypertension","status":"RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2021-07-03","conditions":"Hypertension","enrollment":90},{"nctId":"NCT05272878","phase":"PHASE3","title":"Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-11-22","conditions":"Acute Kidney Injury","enrollment":508},{"nctId":"NCT02472028","phase":"PHASE4","title":"Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Cerebrovascular Disorders","enrollment":820},{"nctId":"NCT04884802","phase":"NA","title":"The GUARDIAN Trial","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-07-25","conditions":"Blood Pressure","enrollment":6254},{"nctId":"NCT06704633","phase":"PHASE4","title":"Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania","status":"NOT_YET_RECRUITING","sponsor":"Martin Rohacek","startDate":"2026-01-05","conditions":"Heart Failure","enrollment":238},{"nctId":"NCT07124728","phase":"NA","title":"Syntrillo Telehealth Stroke Risk Reduction Study","status":"NOT_YET_RECRUITING","sponsor":"Syntrillo, Inc","startDate":"2025-08","conditions":"Hypertension, Hypertension (HTN), Stroke Prevention","enrollment":68},{"nctId":"NCT07098897","phase":"PHASE3","title":"To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Affiliated Hospital of Xuzhou Medical University","startDate":"2024-08-01","conditions":"IgA Nephropathy (IgAN)","enrollment":150},{"nctId":"NCT05806138","phase":"PHASE2","title":"A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-07-17","conditions":"Breast Cancer, Cardiac Dysfunction","enrollment":21},{"nctId":"NCT05841498","phase":"NA","title":"Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome","status":"COMPLETED","sponsor":"University Medical Center Mainz","startDate":"2023-05-08","conditions":"Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition","enrollment":40},{"nctId":"NCT05237323","phase":"PHASE3","title":"Micophenolate Mofetil Versus Azathioprine in Myocarditis","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2020-10-01","conditions":"Lymphocytic Myocarditis (Disorder), Heart Failure, Dilated Cardiomyopathy","enrollment":50},{"nctId":"NCT01471834","phase":"NA","title":"Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"CVRx, Inc.","startDate":"2011-06","conditions":"High Blood Pressure","enrollment":40},{"nctId":"NCT06676384","phase":"PHASE4","title":"Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?","status":"RECRUITING","sponsor":"Christian Medical College, Vellore, India","startDate":"2025-02-15","conditions":"IgA Nephropathy, Renal Insufficiency, Chronic, IgA Vasculitis","enrollment":585},{"nctId":"NCT06562582","phase":"PHASE4","title":"STunning in Acute Myocardial Infarction - BAS","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2025-01-06","conditions":"Myocardial Infarct","enrollment":120},{"nctId":"NCT04864145","phase":"NA","title":"Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2021-05-21","conditions":"Aortic Valve Disease","enrollment":210},{"nctId":"NCT06930092","phase":"NA","title":"RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-07-01","conditions":"Ischemic Cardiomyopathy","enrollment":158},{"nctId":"NCT06564909","phase":"PHASE2","title":"Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMI","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-06-01","conditions":"Reperfusion Injury, Myocardial, Myocardial Infarction","enrollment":76},{"nctId":"NCT05942053","phase":"PHASE4","title":"Role of Vitamin K2 in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-07-15","conditions":"Chronic Kidney Diseases","enrollment":44},{"nctId":"NCT03686306","phase":"PHASE3","title":"VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rennes University Hospital","startDate":"2021-11-24","conditions":"Peripheral Artery Disease","enrollment":106},{"nctId":"NCT04183101","phase":"PHASE2","title":"Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy","status":"RECRUITING","sponsor":"Region Skane","startDate":"2020-10-01","conditions":"C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality","enrollment":30},{"nctId":"NCT07032116","phase":"","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1","status":"NOT_YET_RECRUITING","sponsor":"Liu Hongfang","startDate":"2025-08-01","conditions":"Diabetic Kidney Disease (DKD)","enrollment":4472},{"nctId":"NCT05942027","phase":"PHASE4","title":"Role of Coenzyme Q10 in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-07-15","conditions":"Chronic Kidney Diseases","enrollment":44},{"nctId":"NCT06681896","phase":"NA","title":"Microvascular Coronary Rehabilitation For Improving Treatment - Feasibility Study","status":"RECRUITING","sponsor":"Royal United Hospitals Bath NHS Foundation Trust","startDate":"2024-11-12","conditions":"Microvascular Coronary Dysfunction, Microvascular Angina, Coronary Microvascular Dysfunction (CMD)","enrollment":40},{"nctId":"NCT04899206","phase":"","title":"ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA","status":"WITHDRAWN","sponsor":"Sebastian Videla","startDate":"2021-04-12","conditions":"ACE Inhibitors, ARB, Hypertension","enrollment":""},{"nctId":"NCT04962711","phase":"NA","title":"Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)","status":"RECRUITING","sponsor":"Baker Heart and Diabetes Institute","startDate":"2023-03-30","conditions":"Heart Failure","enrollment":685},{"nctId":"NCT06964217","phase":"","title":"Immediate Fracture Risk After Antihypertensive Drug Initiation","status":"NOT_YET_RECRUITING","sponsor":"Ajou University School of Medicine","startDate":"2025-06-01","conditions":"Hypertension, Fracture","enrollment":10000000},{"nctId":"NCT04491136","phase":"PHASE4","title":"Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-11-11","conditions":"Heart Failure","enrollment":201},{"nctId":"NCT03180450","phase":"PHASE1, PHASE2","title":"The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT06788314","phase":"PHASE2","title":"A Study of Enalapril in Treatment of Venous Malformations","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2025-02-01","conditions":"Venous Malformation, Pain, Quality of Life","enrollment":12},{"nctId":"NCT03746054","phase":"PHASE3","title":"Evaluation of a Cardiovascular Active Prevention in Chronic Myeloid Leukemia on the Cardiovascular Morbi-mortality","status":"TERMINATED","sponsor":"University Hospital, Angers","startDate":"2019-12-20","conditions":"Chronic Myeloid Leukemia (CML)","enrollment":80},{"nctId":"NCT04525729","phase":"PHASE4","title":"Rituximab and RASi in Patients with IgAN","status":"COMPLETED","sponsor":"Nan Chen,MD","startDate":"2020-07-01","conditions":"IgA Nephropathy","enrollment":116},{"nctId":"NCT05572957","phase":"NA","title":"LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-10-14","conditions":"Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block","enrollment":50},{"nctId":"NCT02378805","phase":"","title":"Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome","status":"RECRUITING","sponsor":"University Hospital Goettingen","startDate":"1995-07","conditions":"Alport Syndrome, Hereditary Kidney Disease, Pediatric Kidney Disease","enrollment":800},{"nctId":"NCT02901977","phase":"PHASE4","title":"Doxazosin and Ramipril in Hypertension","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2011-03","conditions":"Hypertension","enrollment":71},{"nctId":"NCT06851845","phase":"","title":"Clinical Outcomes of C3 Glomerulopathy and IC-MPGN in Russia: Hybrid Retrospective - Prospective Study","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-02-01","conditions":"Kidney Diseases","enrollment":100},{"nctId":"NCT06450522","phase":"NA","title":"Post-Discharge Pharmacist-led Rapid Medication Optimization for Heart Failure (Post-Discharge PHARM-HF)","status":"TERMINATED","sponsor":"University of British Columbia","startDate":"2024-07-04","conditions":"Heart Failure with Reduced Ejection Fraction HFrEF","enrollment":12},{"nctId":"NCT04637152","phase":"PHASE2","title":"Sacubitril/Valsartan in Resistant Hypertension","status":"COMPLETED","sponsor":"Hospital Geral Roberto Santos","startDate":"2020-11-11","conditions":"Resistant Hypertension, Blood Pressure","enrollment":80},{"nctId":"NCT04977180","phase":"PHASE2","title":"Cardioprotection in AML","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2022-03-04","conditions":"AML, Acute Myeloid Leukemia","enrollment":70},{"nctId":"NCT03122834","phase":"","title":"Effect of Genetic Polymorphism on the Clinical Outcome of Patients With Heart Failure","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-04-15","conditions":"Heart Failure","enrollment":246},{"nctId":"NCT05259137","phase":"PHASE2, PHASE3","title":"Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars","status":"WITHDRAWN","sponsor":"Nova Scotia Health Authority","startDate":"2024-08","conditions":"Hypertrophic Scar","enrollment":""},{"nctId":"NCT05498675","phase":"","title":"Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2021-09-01","conditions":"Sacubitril/Valsartan, Hypertension, Obesity","enrollment":180},{"nctId":"NCT06247371","phase":"NA","title":"Impact of a Novel Heart Failure Medication Decision Aid","status":"COMPLETED","sponsor":"National University of Singapore","startDate":"2024-04-09","conditions":"Heart Failure","enrollment":150},{"nctId":"NCT01623492","phase":"","title":"Eisenmenger Quality Enhancement Research Initiative","status":"COMPLETED","sponsor":"Actelion","startDate":"2012-07-01","conditions":"Pulmonary Arterial Hypertension","enrollment":193}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":223,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Control group"],"phase":"marketed","status":"active","brandName":"ACEI treatment","genericName":"ACEI treatment","companyName":"Children's Hospital of Fudan University","companyId":"children-s-hospital-of-fudan-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ACE inhibitors block the angiotensin-converting enzyme, reducing the production of angiotensin II and lowering blood pressure. Used for Hypertension, Heart failure, Post-myocardial infarction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}